KONINKLIJKE PHILIPS N.V. (PHG)

Price$29.19

Favorite Metrics

Price vs S&P 500 (26W)-1.99%

Price vs S&P 500 (4W)-0.78%

Market Capitalization$28.38B

P/E Ratio (Annual)26.92x

Indicated Dividend Yield (Annual)0.00%

All Metrics

P/CF (Annual)20.74x

Book Value / Share (Quarterly)$13.57

P/TBV (Annual)2.64x

Indicated Dividend (Annual)$1.00

Revenue Growth (3Y)0.01%

Cash Flow / Share (Quarterly)$0.61

Payout Ratio (TTM)77.54%

Price vs S&P 500 (YTD)3.56%

Gross Margin (TTM)45.43%

Net Profit Margin (TTM)5.23%

EPS (TTM)$1.10

10-Day Avg Trading Volume1.24M

EPS Excl Extra (TTM)$1.10

Revenue Growth (5Y)0.59%

EPS (Annual)$1.11

Dividend / Share (Annual)$0.41

ROI (Annual)4.77%

Gross Margin (Annual)45.18%

Net Profit Margin (5Y Avg)1.78%

Cash / Share (Quarterly)$3.46

P/E Basic Excl Extra (TTM)27.01x

Revenue Growth QoQ (YoY)1.05%

EPS Growth (5Y)-5.30%

P/E Normalized (Annual)26.92x

ROA (Last FY)3.32%

Revenue Growth TTM (YoY)-24.91%

EBITD / Share (TTM)$3.15

ROE (5Y Avg)1.86%

Operating Margin (TTM)8.08%

Cash Flow / Share (Annual)$0.61

P/B Ratio2.20x

P/B Ratio (Quarterly)2.02x

Net Income / Employee (Annual)$0

EV / Revenue (TTM)2.17x

Net Interest Coverage (TTM)7.72x

ROA (TTM)3.34%

EV / EBITDA (TTM)11.53x

EPS Incl Extra (Annual)$1.11

Current Ratio (Annual)1.32x

Quick Ratio (Quarterly)0.94x

3-Month Avg Trading Volume1.51M

52-Week Price Return14.59%

EV / Free Cash Flow (Annual)59.49x

P/E Incl Extra (TTM)27.01x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$10.39

P/S Ratio (Annual)1.35x

Asset Turnover (Annual)0.66x

52-Week High$27.70

Operating Margin (5Y Avg)0.99%

EPS Excl Extra (Annual)$1.11

CapEx CAGR (5Y)-5.68%

Tangible BV CAGR (5Y)-1.12%

26-Week Price Return6.75%

Quick Ratio (Annual)0.92x

13-Week Price Return-3.20%

Total Debt / Equity (Annual)0.71x

Current Ratio (Quarterly)1.32x

Enterprise Value$34,616.67

Revenue / Share Growth (5Y)0.79%

Asset Turnover (TTM)0.50x

Book Value / Share Growth (5Y)-1.72%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)3.22x

Pretax Margin (Annual)6.63%

Cash / Share (Annual)$3.46

3-Month Return Std Dev35.38%

Gross Margin (5Y Avg)44.16%

Net Income / Employee (TTM)$0

EBITDA CAGR (5Y)-1.56%

EBITDA Interim CAGR (5Y)-9.72%

ROE (Last FY)8.17%

Net Interest Coverage (Annual)5.90x

EPS Basic Excl Extra (Annual)$1.11

P/FCF (TTM)15.08x

Receivables Turnover (TTM)3.76x

EV / Free Cash Flow (TTM)59.49x

Total Debt / Equity (Quarterly)0.74x

EPS Incl Extra (TTM)$1.10

Receivables Turnover (Annual)4.69x

ROI (TTM)4.69%

Dividend Growth Rate (5Y)216.55%

P/S Ratio (TTM)1.78x

Pretax Margin (5Y Avg)-0.47%

Revenue / Share (Annual)$22.15

Tangible BV / Share (Annual)$10.39

Forward P/E16.19x

Free OCF CAGR (5Y)-22.31%

Price vs S&P 500 (52W)-20.51%

P/E Ratio (TTM)27.01x

Year-to-Date Return6.80%

5-Day Price Return0.24%

EPS Normalized (Annual)$1.11

ROA (5Y Avg)0.96%

Net Profit Margin (Annual)5.02%

Month-to-Date Return6.34%

Cash Flow / Share (TTM)$0.48

EBITD / Share (Annual)$3.08

Operating Margin (Annual)7.98%

LT Debt / Equity (Annual)0.55x

P/CF (TTM)20.74x

ROI (5Y Avg)1.43%

P/E Excl Extra (TTM)27.01x

LT Debt / Equity (Quarterly)0.63x

EPS Basic Excl Extra (TTM)$1.10

P/TBV (Quarterly)2.64x

Payout Ratio (Annual)36.65%

P/B Ratio (Annual)2.02x

Dividend / Share (TTM)$0.41

Inventory Turnover (TTM)3.22x

Pretax Margin (TTM)6.70%

Book Value / Share (Annual)$13.57

Price vs S&P 500 (13W)-6.06%

Net Margin Growth (5Y)-6.05%

Dividend Yield (TTM)1.36%

Beta1.17x

P/FCF (Annual)48.78x

Revenue / Share (TTM)$16.76

ROE (TTM)8.19%

52-Week Low$19.09

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

3.61

3.67

3.77

3.73

Industry Peers — X-Ray Equipment(3)

Symbol	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
PHGKONINKLIJKE PHILIPS N.V.	1.78x	0.59%	45.43%	8.08%	$29.19
GEHCGE HealthCare Technologies Inc. Common Stock	1.65x	3.74%	39.98%	13.40%	$74.15
HOLXHologic Inc	4.11x	1.66%	56.51%	17.56%	$76.01
BFLYButterfly Network, Inc.	14.22x	—	46.85%	-88.53%	$5.49

About

Koninklijke Philips is a diversified global healthcare company operating across three segments. Diagnosis and treatment generates nearly 50% of revenue through imaging systems, ultrasound equipment, and image-guided therapy solutions. Connected care (under 30% of revenue) provides hospital monitoring, analytics, and sleep and respiratory care solutions. Personal health, comprising the remainder, includes oral health and consumer personal care products such as electric toothbrushes and grooming items.